No cutaneous histamine release with buprenorphine?

Girotra, Sumir; Atray, R.; Mittal, Medha

doi:10.1111/j.1399-6576.1990.tb03090.x

Cited by 3 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Z drugiej strony, tramadol oraz fentanyl i jego pochodne (sufentanyl, alfentanyl, remifentanyl) odznaczają się najmniejszym potencjałem aktywacji komórek tucznych [16,17] oraz niskim ryzykiem wywołania reakcji anafilaktycznej [1]. Dane dotyczące bezpieczeństwa stosowania buprenorfiny, oksykodonu i metadonu u chorych na mastocytozę są sprzeczne lub niepełne [17][18][19][20]. W prezentowanym przypadku chory od kilku miesięcy był leczony oksykodonem w postaci tabletek o kontrolowanym uwalnianiu.…”

Section: Omówienieunclassified

Fentanyl buccal tablet for the treatment of breakthrough pain in systemic mastocytosis – a case study

Zasowska-Nowak¹,

Ciałkowska-Rysz²

2020

View full text Add to dashboard Cite

Section: Omówienieunclassified

Fentanyl buccal tablet for the treatment of breakthrough pain in systemic mastocytosis – a case study

Zasowska-Nowak¹,

Ciałkowska-Rysz²

2020

View full text Add to dashboard Cite

“…Histamine is released by a variety of drugs used in anaesthesia, and may influence the cardiovascular system and bronchomotor tone. Pethidine, morphine, fentanyl and diclofenac given either subcutaneously or intravenously release histamine [23,24,25], whereas nalbuphine [23] and buprenorphine [26] reputedly do not. Changes in heart rate and blood pressure also occur in response to painful operative stimuli, and occur at different times during adenotonsillectomy, septorhinoplasty and tympanomyringoplasty.…”

Section: Discussionmentioning

confidence: 99%

Analgesics and ENT surgery. A clinical comparison of the intraoperative, recovery and postoperative effects of buprenorphine, diclofenac, fentanyl, morphine, nalbuphine, pethidine and placebo given intravenously with induction of anaesthesia.

Berg

Honjol

Prabhu

et al. 1994

Brit J Clinical Pharma

View full text Add to dashboard Cite

1 Vomiting and restlessness following ENT and eye surgery are undesirable, and may be related to the emetic and analgesic effects of any analgesic given to augment anaesthesia during surgery. 2 To rationalise the choice of analgesic for routine ENT surgery we examined the intraoperative, recovery and postoperative effects following the administration of either buprenorphine (3.0 to 4.5 pg kg-'), diclofenac (1 mg kg-'), fentanyl (1.5 to 2.0 pg kg-'), morphine (0.1 to 0.15 mg kg-'), nalbuphine (0.1 to 0.15 mg kg-'), pethidine (1.0 to 1.5 mg kg-') or saline (as control) given with the induction of anaesthesia in 374 patients. A standardised anaesthetic technique with controlled ventilation using 0.6-0.8% isoflurane in nitrous oxide and oxygen was employed. The study population constituted 7 similar groups of patients. 3 Intraoperatively, their effects on heart rate and blood pressure, airway pressure and intraocular pressure, were similar. This implies, most surprisingly, that neither their analgesic nor their histamine releasing effects were clinically evident during surgery. By prolonging the time to extubation at the end of anaesthesia, only buprenorphine, fentanyl, morphine and pethidine provided evidence of intraoperative respiratory depression. 4 Postoperatively, buprenorphine was associated with severe respiratory depression, prolonged somnolence, profound analgesia and the highest emesis rate. Diclofenac exhibited no sedative, analgesic, analgesic sparing, emetic or antipyretic effects. Fentanyl provided no sedative or analgesic effects, but was mildly emetic. Morphine provided poor sedation and analgesia, delayed the requirement for re-medication and was highly emetic. Nalbuphine and pethidine produced sedation with analgesia during recovery, a prolonged time to re-medication and a mild emetic effect. None provided evidence, from analysis of postoperative re-medication times and analgesic consumption, of any pre-emptive analgesic effect.5 We conclude that nalbuphine (mean dose 0.13 mg kg-') and pethidine (mean dose 1.35 mg kg-'), given individually as a single i.v. bolus during induction of anaesthesia, are the most efficacious analgesics for routine in-patient ENT surgery.

show abstract

Apparition d’œdèmes périphériques lors d’un switch de la buprénorphine seule vers l’association buprénorphine–naloxone : à propos d’un cas

et al. 2016

View full text Add to dashboard Cite

No cutaneous histamine release with buprenorphine?

Cited by 3 publications

References 20 publications

Fentanyl buccal tablet for the treatment of breakthrough pain in systemic mastocytosis – a case study

Fentanyl buccal tablet for the treatment of breakthrough pain in systemic mastocytosis – a case study

Analgesics and ENT surgery. A clinical comparison of the intraoperative, recovery and postoperative effects of buprenorphine, diclofenac, fentanyl, morphine, nalbuphine, pethidine and placebo given intravenously with induction of anaesthesia.

Apparition d’œdèmes périphériques lors d’un switch de la buprénorphine seule vers l’association buprénorphine–naloxone : à propos d’un cas

Contact Info

Product

Resources

About